# Hydroquinidine Versus Placebo in Patients With Brugada Syndrome

> **NCT00927732** · PHASE3 · TERMINATED · sponsor: **Nantes University Hospital** · enrollment: 64 (actual)

## Conditions studied

- Brugada Syndrome

## Interventions

- **DRUG:** hydroquinidine
- **DRUG:** placebo (sugar)

## Key facts

- **NCT ID:** NCT00927732
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-02
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 64 (ACTUAL)
- **Why stopped:** insufficient recruitment, a lot of premature study discontinuations
- **Last updated:** 2014-11-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00927732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00927732, "Hydroquinidine Versus Placebo in Patients With Brugada Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00927732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*